Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
View Patent ↗The invention provides transgene constructs for expressing chimeric antibodies, and transgenic non-human host animals carrying such constructs, wherein the chimeric antibodies comprise human variable regions and constant regions of the non-human transgenic host animal. The presence of immunoglobulin constant regions of the host animal allows for generation of improved antibodies in such transgenic host animals. Subsequently, the chimeric antibodies can be readily converted to fully human antibodies using recombinant DNA techniques. Thus, the invention provides compositions and methods for generating human antibodies in which chimeric antibodies raised in vivo in transgenic mice are used as intermediates and then converted to fully human antibodies in vitro.
1. A transgene construct comprising an unrearranged human heavy chain immunoglobulin (Ig) variable region sequence operatively linked to a mouse immunoglobulin (Ig) constant region sequence, wherein said constant region sequence comprises, in 5′ to 3′ direction, an approximately 140kb NgoMIV-NotI fragment of the B20 bacteria artificial chromosome (BAC) and an approximately 180kb NotI-NotI frag of the C22 BAC, and wherein, when integrated into a mouse genome, said transgene construct undergoes rearrangement and the mouse expresses chimeric antibodies, wherein the chimeric antibodies comprise a human heavy chain variable region and a mouse heavy chain constant region.
2. The construct of claim 1 , wherein the unrearranged human heavy chain variable region sequence comprises human heavy chain V segment sequences, human heavy chain D segment sequences, and human heavy chain J segment sequences.
3. The construct of claim 2 , which comprises, in 5′ to 3′ direction, a plurality of human heavy chain V segment sequences, a plurality of human heavy chain D segment sequences, a plurality of human heavy chain J segment sequences, and said mouse constant region sequence.
4. The construct of claim 3 , which comprises four human heavy chain V segment sequences, 15 human heavy chain D segment sequences and six human heavy chain J segment sequences.
5. The construct of claim 4 , which comprises a Hco26 transgene.
6. A transgenic mouse whose genome comprises the transgene construct of claim 1 , wherein the mouse expresses chimeric antibodies comprising human Ig variable regions and mouse Ig constant regions.
7. A method of making a chimeric antibody specific for an antigen of interest comprising immunizing the transgenic mouse of claim 6 with the antigen of interest and obtaining from the mouse a chimeric antibody specific for the antigen of interest.
8. The method of claim 7 , further comprising isolating from the mouse a nucleic acid encoding a chimeric immunoglobulin (Ig) heavy chain and replacing nucleic acid encoding the mouse Ig heavy chain constant region with nucleic acid encoding a human Ig heavy chain constant region to convert the nucleic acid encoding the chimeric Ig heavy chain to a nucleic acid encoding a human Ig heavy chain, and expressing the human Ig heavy chain.